Chemours(CC)
Search documents
Chemours(CC) - 2022 Q2 - Earnings Call Presentation
2022-07-29 14:12
| --- | --- | --- | --- | --- | |------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Chemours 2Q 2022 Earnings Presentation July 28, 2022 | | | | | | | | | | | Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-look ...
Chemours(CC) - 2022 Q1 - Earnings Call Presentation
2022-05-05 03:16
| --- | --- | --- | --- | --- | |----------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Chemours 1Q 2022 Earnings Presentation | | | | | | May 2, 2022 | | | | | Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements ...
Chemours(CC) - 2022 Q1 - Earnings Call Transcript
2022-05-03 17:00
Call Start: 08:30 January 1, 0000 9:16 AM ET The Chemours Company (NYSE:CC) Q1 2022 Earnings Conference Call May 3, 2022, 8:30 AM ET Company Participants Mark Newman – President, Chief Executive Officer Sameer Ralhan – Senior Vice President, Chief Financial Officer Jonathan Lock – Senior Vice President, Chief Development Officer Conference Call Participants John McNulty – BMO Capital Markets Arun Viswanathan – RBC Capital Markets James Cannon – UBS Michael Leithead – Barclays Hassan Ahmed – Alembic Global A ...
Chemours(CC) - 2022 Q1 - Quarterly Report
2022-05-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. ...
Chemours(CC) - 2021 Q4 - Earnings Call Transcript
2022-02-11 20:17
The Chemours Company (NYSE:CC) Q4 2021 Earnings Conference Call February 11, 2022 8:30 AM ET Company Participants Mark Newman – President and Chief Executive Officer Sameer Ralhan – Senior Vice President and Chief Financial Officer Jonathan Lock – Senior Vice President and Chief Development Officer Conference Call Participants John Silverstein – Wolfe Research John McNulty – BMO Emily Chen – Goldman Sachs Arun Viswanathan – RBC Capital Markets Duffy Fischer – Barclays Vincent Andrews – Morgan Stanley Josh S ...
Chemours(CC) - 2021 Q4 - Earnings Call Presentation
2022-02-11 16:03
The Chemours Company Fourth Quarter & Full Year 2021 Earnings Presentation February 11, 2022 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a hi ...
Chemours(CC) - 2021 Q4 - Annual Report
2022-02-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Emplo ...
Chemours(CC) - 2021 Q3 - Earnings Call Transcript
2021-11-05 19:36
The Chemours Company (NYSE:CC) Q3 2021 Earnings Conference Call November 5, 2021 8:30 AM ET Company Participants Jonathan Lock - Vice President of Corporate Development & Investor Relations Mark Newman - President and Chief Executive Officer Sameer Ralhan - Senior Vice President and Chief Financial Officer Conference Call Participants John McNulty - BMO Capital Markets Hassan Ahmed - Alembic Global Advisors Bob Koort - Goldman Sachs Josh Spector - UBS Matthew DeYoe - Bank of America Merrill Lynch Duffy Fisc ...
Chemours(CC) - 2021 Q3 - Earnings Call Presentation
2021-11-05 13:59
The Chemours Company Third Quarter 2021 Earnings Presentation November 5, 2021 Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current f ...
Chemours(CC) - 2021 Q3 - Quarterly Report
2021-11-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of Incorporation or Organization) (I.R ...